Oruka Therapeutics Inc (ORKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,025 | 7,763 | 7,740 | 32,061 | 60,335 |
| Marketable Securities | N/A | N/A | N/A | 65,506 | 92,791 |
| Receivables | N/A | N/A | N/A | 588 | 8,559 |
| Other current assets | 137 | 195 | 1,938 | 1,831 | 4,650 |
| TOTAL | $7,162 | $7,958 | $9,678 | $99,986 | $166,335 |
| Non-Current Assets | |||||
| PPE Net | 690 | 1,026 | 1,303 | 8,906 | 11,978 |
| Intangibles | 0 | 0 | 0 | 4,671 | 4,671 |
| Other Non-Current Assets | 304 | 388 | 98 | 7,120 | 1,421 |
| TOTAL | $994 | $1,414 | $1,401 | $20,697 | $18,070 |
| Total Assets | $8,156 | $9,372 | $11,079 | $120,683 | $184,405 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | N/A | 3,659 |
| Accounts payable and accrued liabilities | 388 | 533 | 804 | 2,307 | 7,026 |
| Accrued Expenses | 175 | 241 | 1,071 | 5,582 | 19,685 |
| Other current liabilities | 506 | 756 | 1,549 | 8,648 | 8,487 |
| TOTAL | $1,190 | $1,644 | $15,830 | $18,187 | $43,839 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | N/A | 125 |
| Deferred Revenues | 121 | 114 | 107 | 1,650 | 4,982 |
| Other Non-Current Liabilities | 0 | 0 | 32,997 | 13,177 | 19,067 |
| TOTAL | $195 | $316 | $33,427 | $34,837 | $70,723 |
| Total Liabilities | $1,385 | $1,960 | $49,257 | $53,024 | $114,562 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1 | 1 | 1 | 53,506 | 53,243 |
| Common Shares | 9 | 8 | 1 | 3 | 53 |
| Retained earnings | -58,310 | -49,890 | -40,752 | -470,513 | -458,212 |
| Other shareholders' equity | 0 | 0 | 0 | 49 | 10 |
| TOTAL | $6,771 | $7,412 | $-38,178 | $67,659 | $69,843 |
| Total Liabilities And Equity | $8,156 | $9,372 | $11,079 | $120,683 | $184,405 |